Clinical Trial Details
EORTC-20852
Back to Clinical Trials Database
Phase II Salvage Chemotherapy with M-CAVe (CTX/ADR/VBL/MTX) Alternating with CEC (CCNU/VP-16/CLB) in MOPP-Refractory Hodgkin's Disease
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-Aug-1985 Date Step1 close: 15-Nov-1987 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 20 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
